1-4 of 4
Hedwig E. Deubzer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeted Analysis of Cell-free Circulating Tumor DNA is Suitable for Early Relapse and Actionable Target Detection in Patients with Neuroblastoma

Marco Lodrini, Josefine Graef, Theresa M. Thole-Kliesch, Kathy Astrahantseff, Annika Sprüssel, Maddalena Grimaldi, Constantin Peitz, Rasmus B. Linke, Jan F. Hollander, Erwin Lankes, Annette Künkele, Lena Oevermann, Georg Schwabe, Jörg Fuchs, Annabell Szymansky, Johannes H. Schulte, Patrick Hundsdörfer, Cornelia Eckert, Holger Amthauer, Angelika Eggert, Hedwig E. Deubzer
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (9): 1809–1820.
https://doi.org/10.1158/1078-0432.CCR-21-3716
Published: 02 May 2022
View article titled, Targeted Analysis of Cell-free Circulating Tumor DNA is Suitable for Early Relapse and Actionable Target Detection in Patients with Neuroblastoma
Open the PDF for Targeted Analysis of Cell-free Circulating Tumor DNA is Suitable for Early Relapse and Actionable Target Detection in Patients with Neuroblastoma in another window
Includes: Supplementary data
Journal Articles

HDAC5 and HDAC9 in Medulloblastoma: Novel Markers for Risk Stratification and Role in Tumor Cell Growth

Till Milde, Ina Oehme, Andrey Korshunov, Annette Kopp-Schneider, Marc Remke, Paul Northcott, Hedwig E. Deubzer, Marco Lodrini, Michael D. Taylor, Andreas von Deimling, Stefan Pfister, Olaf Witt
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (12): 3240–3252.
https://doi.org/10.1158/1078-0432.CCR-10-0395
Published: 14 June 2010
View article titled, HDAC5 and HDAC9 in Medulloblastoma: Novel Markers for Risk Stratification and Role in Tumor Cell Growth
Open the PDF for HDAC5 and HDAC9 in Medulloblastoma: Novel Markers for Risk Stratification and Role in Tumor Cell Growth in another window
Includes: Supplementary data
Journal Articles

Histone Deacetylase 8 in Neuroblastoma Tumorigenesis

Ina Oehme, Hedwig E. Deubzer, Dennis Wegener, Diana Pickert, Jan-Peter Linke, Barbara Hero, Annette Kopp-Schneider, Frank Westermann, Scott M. Ulrich, Andreas von Deimling, Matthias Fischer, Olaf Witt
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (1): 91–99.
https://doi.org/10.1158/1078-0432.CCR-08-0684
Published: 31 December 2008
View article titled, Histone Deacetylase 8 in Neuroblastoma Tumorigenesis
Open the PDF for Histone Deacetylase 8 in Neuroblastoma Tumorigenesis in another window
Includes: Supplementary data
Journal Articles

Cisplatin-Resistant Neuroblastoma Cells Express Enhanced Levels of Epidermal Growth Factor Receptor (EGFR) and Are Sensitive to Treatment with EGFR-Specific Toxins

Martin Michaelis, Jennifer Bliss, Sonja C. Arnold, Nora Hinsch, Florian Rothweiler, Hedwig E. Deubzer, Olaf Witt, Klaus Langer, Hans W. Doerr, Winfried S. Wels, Jindrich Cinatl, Jr.
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (20): 6531–6537.
https://doi.org/10.1158/1078-0432.CCR-08-0821
Published: 16 October 2008
View article titled, Cisplatin-Resistant Neuroblastoma Cells Express Enhanced Levels of Epidermal Growth Factor Receptor (EGFR) and Are Sensitive to Treatment with EGFR-Specific Toxins
Open the PDF for Cisplatin-Resistant Neuroblastoma Cells Express Enhanced Levels of Epidermal Growth Factor Receptor (EGFR) and Are Sensitive to Treatment with EGFR-Specific Toxins in another window